基本信息 | |
---|---|
产品编号 | CHCC-74690 |
产品名称 | MIA PaCa-2 |
产品分类
P R O D U C T
关于我们

北京中检航标计量技术有限公司成立于北京,是一家致力于为实验室分析领域提供全套服务产品的高科技公司。目前公司已是集研发、生产与销售为一体的综合性企业。总部位于北京,物流遍布中国各地区,为用户提供专业化,快捷化的一站式服务。微生物资源平台(网址www. rmweb.com.cn ),隶属于北京中检航标计量技术有限公司。公司能够面向全国的科学工作者提供超60余万种的各类标准物质、进口标准品、微生物菌种、国际菌种、生命科学、实验耗材、培养基、色谱柱、实验仪器等科研用品。
企业优势






联系方式

业务电话
400-662-9888

售后电话
18611656588

投诉电话
18611656588

邮箱
info@gbwpt.com

应用领域
详细信息
MIA PaCa-2
(ATCC® CRM-CRL-1420™) 编号
Organism 微生物 : Homo sapiens, human /
Cell Type 细胞类型 : epithelial cell (KRAS CRM) /
Tissue: pancreas /
Disease: carcinoma
Organism Homo sapiens, human
Tissue pancreas
Cell Type epithelial cell (KRAS CRM)
Product Format 提供形式 frozen
Morphology attached epithelial with floating rounded cells
Culture Properties adherent, single cells and loosely attached clusters
Biosafety Level 生物安全等级1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.
Disease carcinoma Age 65 years Gender Male Ethnicity Caucasian
Applications 用途 For use in testing and calibration in ISO 17025 accredited laboratories, to challenge assay performance, validate or compare test methods, and to establish sensitivity, linearity and specificity during assay validation or implementation. ISO Guide 34:2009
Intended Use
Certified Reference Material produced under an ISO Guide 34:2009 accredited process.
Storage Conditions 保藏方法 liquid nitrogen vapor phase
Karyotype
This is a hypotriploid human cell line. The modal chromosome number is 61. Sixteen to 20 marker chromosomes are commonly found in a cell. A few normal chromosomes are absent.
Derivation The MIA PaCa-2 cell line was established by A. Yunis, et al. in 1975 from tumor tissue of the pancreas obtained from a 65-year-old Caucasian male.
Hybridomas have been made against the CSF-I produced by this line ATCC HB-8207 (F1A3-23) and ATCC HB-8208 (F18 AF1).
Clinical Data 65 years Caucasian male
Genes Expressed human colony stimulating factor, subclass I (CSF-I); plasminogen activator
Cellular Products human colony stimulating factor, subclass I (CSF-I); plasminogen activator
CommentsCertificates of Analysis are available electronically at www.atcc.org, or by hardcopy upon request.
Certified Reference Material produced under an ISO Guide 34:2009 accredited process.
Item has been tested for KRAS mutation (p.G12C c.34G>T)
The established cell line reportedly has a doubling time of about 40 hours and a colony-forming efficiency in soft agar of approximately 19%.
The line is sensitive to asparaginase. Complete Growth Medium
The base medium for this cell line is ATCC-formulated Dulbecco's Modified Eagle's Medium, Catalog No. 30-2002. To make the complete growth medium, add the following components to the base medium: fetal bovine serum to a final concentration of 10%; horse serum to a final concentration of 2.5%.
Subculturing
Protocol: Remove medium, and rinse with 0.25% trypsin, 0.53 mM EDTA solution. Remove the solution and add an additional 1 to 2 mL of trypsin-EDTA solution. Allow the flask to sit at room temperature (or at 37℃) until the cells detach. Add fresh culture medium, aspirate and dispense into new culture flasks.
Subcultivation Ratio: A subcultivation ratio of 1:3 to 1:8 is recommended
Medium Renewal: 2 to 3 times per week
Cryopreservation Freeze Medium: Complete growth medium 95%; DMSO, 5%
Storage Temperature 保藏温度 : Liquid nitrogen vapor phase
Culture Conditions 培养条件
Temperature 培养温度 : 37℃STR Profile
Amelogenin: X
CSF1PO: 10
D13S317: 12,13
D16S539: 10,13
D5S818: 12,13
D7S820: 12,13
THO1: 9,10
TPOX: 9
vWA: 15
Isoenzymes G6PD, B
Name of Depositor A Yunis
Year of Origin 1975
References 参考文献 Wu M, et al. Purification and characterization of a plasminogen activator secreted by cultured human pancreatic carcinoma cells. Biochemistry 16: 1908-1913, 1977. PubMed: 15590
Fountzilas G, et al. Comparative effects of selected drug combinations on the growth of a human pancreatic carcinoma cell line (MIA PaCa-2). J. Natl. Cancer Inst. 76: 37-43, 1986. PubMed: 3455740
Robertson JF, et al. Effect of gastrointestinal hormones and synthetic analogues on the growth of pancreatic cancer. Int. J. Cancer 63: 69-75, 1995. PubMed: 7558455
Yunis AA, et al. Human pancreatic carcinoma (MIA PaCa-2) in continuous culture: sensitivity to asparaginase. Int. J. Cancer 19: 128-135, 1977. PubMed: 832918